The MolBio-PSMA study

in the study, we establish a biobank, with the main objective to study biomarkers in circulating blood in a cohort with optimal staging with PSMA-PET/CT.

Among others, we study patients with newly diagnosed prostate cancer and primary staging with PSMA PET/CT and study the correlation between circulating tumor-DNA, mutation-profile and other biomarkers against whole-body tumor burden, disease stage, treatment outcome etc.

The aim is to develop new non-invasive biomarkers for diagnosis, prognosis and risk-evaluation of prostate cancer patients that can hopefully guide treatment choice for the individual patient.

The study is performed in close collaboration between Department of Nuclear Medicine and PET-Centre, Department of Urology and Department of Molecular Medicine (MOMA).